Breast health is important and taking preventive measures reduces your risk of breast cancer. Breast screening early can also assist in early diagnosis and care. Women aged 40 and over are encouraged to participate in breast cancer screening each year.
BC Women’s and BC Cancer have launched a research initiative as part of a multicentre study led by lead researchers from the Beth Israel Deaconess Medical Center, Harvard University, in Boston, Massachusetts and Sunnybrook Hospital and Research Institute in Toronto, Ontario, in March.
BC Women’s is inviting women aged 40 and older to register and enroll in a randomized clinical trial. Women who participate will have the opportunity to receive either 2D mammograms or 3D Tomosynthesis combined with 2D mammograms annually for 3 years. Those enrolled will have their screening data archived which will be used to help in the development and testing of technologies to improve breast cancer detection.
The study will assess and compare Tomosynthesis imaging with digital mammography (which is the current standard of care in BC). Tomosynthesis mammography is a 3-D breast cancer screening method that has been shown in multiple studies to be more accurate than traditional 2D mammography. It has been shown that 3D Tomosynthesis allows for better imaging of the breast, higher breast cancer detection accuracy, and fewer false-positive results than traditional 2D mammography, however the results are not consistent.
This study will be the first of its kind in Canada to address the existing inconsistent results. The study aims to compare the number of women who are recalled for additional testing from 2D mammography to 2D mammography combined with 3D Tomosynthesis. The study will take approximately 3 years to complete and researchers are very pleased with the current rate of participation.
If you have any questions regarding this study, or are interested in participating please contact the Research Coordinator, Khaye Rufin at
604-875-2424 ext 4796 or email: Khaye.Rufin@cw.bc.ca